What You Should Know:
– Deloitte announced today the acquisition of substantially all assets belonging to Gryphon Scientific, LLC (Gryphon). Gryphon is a leader in biosafety, biosecurity, and all-hazards preparedness and response.
– The combined expertise of Gryphon and Deloitte will fuel the development of practical AI applications in healthcare. Together, they will champion multi-sector collaboration and risk management strategies to create trustworthy AI solutions through the Federal Health AI Accelerator at Deloitte.
Acquisition IMpact for Deloitte & Its Clients
Gryphon brings a wealth of expertise to the table. Their multidisciplinary team, comprised of scientists, programmers, and policy professionals, boasts experience in data science, scientific communication, modeling, and risk assessment. This team will significantly enhance Deloitte’s ability to serve clients facing complex missions.
The acquisition benefits Deloitte’s clients in several ways:
- Enhanced Biosecurity and Public Health Preparedness: Gryphon’s expertise will bolster Deloitte’s life science and public health capabilities, allowing them to better assist clients in preparing for biological emergencies and biothreats. This will strengthen public health and safety on a national scale.
- Advanced Data Science and Risk Assessment: Gryphon’s team brings advanced data science and risk assessment skills, allowing Deloitte to provide more comprehensive solutions for clients facing complex challenges.
- Leadership in AI Safety: Gryphon is a frontrunner in AI safety, particularly regarding the evolving risk landscape of biological and chemical threats posed by AI. This expertise will be instrumental in developing practical and trustworthy AI applications through the Federal Health AI Accelerator at Deloitte.
By combining Deloitte’s extensive resources with Gryphon’s specialized knowledge, this acquisition positions them at the forefront of safeguarding public health and security in a world increasingly shaped by emerging technologies and complex global threats.
“The addition of Gryphon’s leadership and key professionals to the Deloitte team represents a significant enhancement to Deloitte’s data analytics and advanced technology capabilities. Our federal health practice is excited to lead the way for U.S. government and public services (GPS) to push the boundaries and bring our clients to the forefront of AI-enabled, mission-driven work,” said Beth Meagher, principal, Deloitte Consulting LLP and U.S. federal health sector leader. “This enhances the types of data-driven technology and scientific experience that we can offer to federal agencies and strengthens our ability to support government leaders in their efforts to safeguard the security of our nation and the health and safety of our people.”
